Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Lexeo Therapeutics, Inc. (LXEO) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Usual Care, Lx2006Friedreich Ataxia, Cardiomyopathy, SecondaryPhase IIRecruitingStudy of LX2006 Gene Therapy in Friedreich Ataxia CardiomyopathyJun 24, 2026―
Lx2020Arrhythmogenic Cardiomyopathy, Pkp2-Acm, Pkp2-Arvcphase1AndPhase2RecruitingGene Therapy for ACM Due to a PKP2 Pathogenic VariantOct 25, 2023
Low Dose Lx2006, Mid Dose Lx2006, High Dose Lx2006Friedreich Ataxia, Cardiomyopathy, Secondaryphase1AndPhase2Active Not RecruitingGene Therapy for Cardiomyopathy Associated With Friedreich's AtaxiaJun 23, 2022―
Lx1001Alzheimer DiseasePhase IActive Not RecruitingLong-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's DiseaseMay 27, 2022―
Lx1001Alzheimer Disease, Early Onset Alzheimer Diseasephase1AndPhase2CompletedGene Therapy for APOE4 Homozygote of Alzheimer's DiseaseAug 03, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lexeo Therapeutics, Inc. (LXEO) have in its pipeline
Lexeo Therapeutics, Inc. LXEO is currently developing the following drugs: Usual Care, Lx2006, Lx2020, Low Dose Lx2006, Mid Dose Lx2006, High Dose Lx2006, Lx1001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.